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Lack of Sonic hedgehog (Shh) signaling, mediated by the Gli proteins, leads to severe pulmonary hypoplasia. However, the precise role of
Gli genes in lung development is not well established. We show Shh signaling prevents Gli3 proteolysis to generate its repressor forms
(Gli3R) in the developing murine lung. In Shh/ or cyclopamine-treated wild-type (WT) lung, we found that Gli3R level is elevated, and
this upregulation appears to contribute to defects in proliferation and differentiation observed in the Shh/ mesenchyme, where Gli3 is
normally expressed. In agreement, we found Shh/;Gli3/ lungs exhibit enhanced growth potential. Vasculogenesis is also enhanced; in
contrast, bronchial myogenesis remains absent in Shh/;Gli3/ compared with Shh/ lungs. Genes upregulated in Shh/;Gli3/
relative to Shh/ lung include Wnt2 and, surprisingly, Foxf1 whose expression has been reported to be Shh-dependent. Cyclins D1, D2, and
D3 antibody labelings also reveal distinct expression patterns in the normal and mutant lungs. We found significant repression of Tbx2 and
Tbx3, both linked to inhibition of cellular senescence, in Shh/ and partial derepression in Shh/; Gli3/ lungs, while Tbx4 and Tbx5
expressions are less affected in the mutants. Our findings shed light on the role of Shh signaling on Gli3 processing in lung growth and
differentiation by regulating several critical genes.
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Lung development involves a highly orchestrated series
of growth and morphogenetic events, precisely regulated by
complex interactions among signaling molecules and tran-
scription factors (Cardoso, 2001; Costa et al., 2001; Hogan,
1999; Perl and Whitsett, 1999; van Tuyl and Post, 2000;
Warburton et al., 2000; Whitsett, 1998). Reports of lung
abnormalities, both in humans and from mouse models, due
to genetic aberrations, diseases, and environmental factors
abound in the literature. In severe cases, lung hypoplasia has
also been shown concurrently with congenital diaphragmat-
ic hernia (CDH) in humans, with an incidence of 1 in 25000012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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The mammalian Gli gene family consists three mem-
bers, Gli1, Gli2, and Gli3 (Hui et al., 1994; Kinzler et al.,
1988; Ruppert et al., 1988), which encode zinc finger
transcription factors involved in both developmental reg-
ulation and human diseases (Kang et al., 1997; Ming et
al., 1998; Villavicencio et al., 2000; Vortkamp et al.,
1991; Wild et al., 1997). All three Gli genes are
expressed in the lung mesenchyme during the pseudo-
glandular stage of development (Grindley et al., 1997),
and mutations in the Gli genes give rise to various lung
and foregut defects (van Tuyl and Post, 2000). While Gli1
is dispensable for lung development in the presence of
other Gli genes (Park et al., 2000), Gli2/ mutant lung
exhibits right lobe hypoplasia, narrowing of the esophagus
and trachea (Motoyama et al., 1998), and Gli3XtJ mutant
lung, with an intragenic deletion of Gli3 (Hui and Joyner,
1993; Vortkamp et al., 1992), shows an overall growth
defect with a pronounced length reduction of the left
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Gli2 and Gli3 null mice are severely defective in upper
foregut structures lacking lung, trachea, and esophagus.
Gli2/;Gli3+/ foregut displays tracheoesophageal fistula
(TEF) and severe lung growth and lobation defects
(Motoyama et al., 1998). Likewise, Gli1 and Gli2 com-
pound homozygous mutants show severe lung defects (Park
et al., 2000). These findings point to the critical role of the
Gli genes in the development of foregut structures.
Shh is one among several important factors, derived
from the lung endoderm, which is required for prolifer-
ation, differentiation, and patterning of the mesenchyme,
and Shh null mice exhibit foregut anomalies including
hypoplastic lungs due to defects in branching morpho-
genesis (Bellusci et al., 1997a; Litingtung et al., 1998;
Pepicelli et al., 1998). Shh signaling has been implicated
in the regulation of Gli genes (Ruiz, 1999), notably Gli1
and Gli3 transcription in the lung (Litingtung et al.,
1998; Pepicelli et al., 1998). Gli2 has also been impli-
cated in the regulation of Ptch1 and Gli1 (Motoyama et
al., 1998), components of the Shh signaling cascade in
the lung, although Gli2 expression in the Shh/ mutant
lung mesenchyme is unaffected (Pepicelli et al., 1998). It
is possible that Gli2 activator function may be compro-
mised in the absence of Shh signaling (Mill et al., 2003;
Sasaki et al., 1999). Shh signaling has also been shown
to be activated in small cell lung cancer (SCLC) cell
lines, and cyclopamine, a hedgehog signaling antagonist,
was shown to inhibit SCLC tumorigenicity (Watkins et
al., 2003).
Gli3 is a bipotential transcription factor (Dai et al.,
1999, 2002; Motoyama et al., 1998; Sasaki et al., 1999),
and it has been shown that the repressor form of Gli3
(Gli3R), generated as a result of proteolytic cleavage and
lacking amino acids C-terminal to the zinc finger domain,
is activated in the absence of Shh signaling in the
developing limbs (Litingtung et al., 2002; Wang et al.,
2000). Gli3R has been implicated in the regulation of
growth and patterning of the ventral spinal cord (Liting-
tung and Chiang, 2000; Persson et al., 2002; Wijgerde et
al., 2002) and limb (Litingtung et al., 2002; te Welscher et
al., 2002). It appears that while abrogating Shh function
alone results in serious developmental defects, absence of
the Shh signal combined with a lack of Gli3 function can
result in an apparently less severe phenotype.
The effect of Shh signaling on Gli3 processing has
been examined mainly in tissues known to be exposed to
a long-range Shh gradient. However, it is not clear
whether Shh similarly regulates Gli3 processing in the
lung. Furthermore, to what extent Shh-regulated Gli3
processing plays a role in lung development has not
been addressed. Our findings shed light on the important
role of Shh signaling on Gli3 processing and its role in
proliferation and differentiation during lung growth and
patterning, by directly or indirectly regulating the expres-
sion of critical developmental genes.Materials and methods
Embryos
The generation and identification of Shh and Gli3
mutant embryos and mice were performed as previously
described (Litingtung and Chiang, 2000).
Lung organ culture and Western blotting
The lung culture method used (Litingtung et al., 1998),
production of amino terminal-specific Gli3 (Gli3-N) anti-
body, and Western analysis were performed essentially as
previously described (Litingtung et al., 2002). E11.5 wild-
type (WT) lungs were cultured with cyclopamine (gift of
W. Gaffield) in serum-free culture medium at a final
concentration of 4 Ag/ml for 24 h, after which lung lysates
were collected and resolved on 7.5% SDS–polyacrylamide
gel, loading 150 Ag total protein per lane. Lung lysates
were also prepared from freshly dissected E12.5 WT and
Shh/ lungs and analyzed by Western blotting with anti-
bodies against Gli3-N, cyclin D1 (BD Pharmingen, 1:250
dilution) or cyclin E (Santa Cruz, 1:500 dilution).
Analysis of cell proliferation
5-Bromodeoxyuridine (BrdU) in vivo labeling and de-
tection were performed as previously described (Litingtung
et al., 1998). Cells in five different photomicrographs
representing random portions of the WT, Shh/, or
Shh/;Gli3/ lungs were counted. The total number of
epithelial cells counted were 1363, 1915, and 1900, and the
total mesenchymal cells counted were 3911, 2734, and
3126, in WT, Shh/, and Shh/;Gli3/, respectively.
In situ hybridization
Whole-mount and cryosection in situ hybridizations
were performed as previously described (Litingtung et al.,
1998). The following cDNAs were used as templates for
synthesizing digoxygenin-labeled riboprobes: Ptch1 (Good-
rich et al., 1996), Gli1 (Hui et al., 1994), Wnt2 (Huguet et
al., 1994), Foxf1 (Kalinichenko et al., 2001b), Tbx2, Tbx3,
Tbx4, Tbx5 (Chapman et al., 1996), c-myc, and N-myc
(Serra and Moses, 1995).
Immunohistochemistry
Whole-mount staining was performed on E12.5 and
E13.5 embryos using anti-Hnf-3h antibody (kindly provided
by B. Hogan) as described (Litingtung et al., 1998). Label-
ings using antibodies against cyclins D1, D2, and D3 were
performed on 5-Am tissue sections from paraffin-embedded
embryos fixed in 4% paraformaldehyde overnight at 4jC.
Paraffin sections were deparaffinized and rehydrated accord-
ing to standard protocols. Endogenous peroxidase activity
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temperature. To reveal cyclins D1, D2, and D3, sections were
antigen-retrieved using the DAKO target retrieval solution
(pH 6.1), following DAKO’s suggested protocol using a
Black and Decker Handy Steamer. The antibodies used were
mouse anti-cyclin D1 (BD Pharmingen, 1:100 dilution),
rabbit anti-cyclin D2 (Santa Cruz, 1:200 dilution), and
mouse anti-cyclin D3 (Neomarkers, 1:200 dilution). For
signal enhancement, a goat antimouse IgG-HRP or goat
antirabbit IgG-AP polymer-conjugated secondary antibody
from ZYMED Picture-Double staining kit was used, follow-
ing the company’s suggested protocol. For studies on differ-
entiation, E15.5 cryosections collected from embryos fixed
in 4% paraformaldehyde for 4 h at 4jC were used for
immunolabelings; sections were blocked in 10% goat serum
in PBS containing 0.1% triton-X 100 at room temperature for
1 h to reduce nonspecific staining, followed by an overnight
incubation at 4jC with the following primary antibodies: rat
anti-mouse PECAM-1/CD31 (BD Pharmingen, clone MEC
13.3, 1:100 dilution), rat anti-Flk-1 (BD Pharmingen, 1:50
dilution), mouse antismooth muscle alpha-actin (SMA) (Sig-
ma, clone 1A4, 1:300 dilution), and rabbit anti-smooth
muscle myosin II heavy chain (SMM) (BioMedical Tech-
nologies, 1:150 dilution). Sections were washed with several
rinses of PBS containing 0.1% Tween-20 (Sigma). Alexa
488 (green)- or Alexa 568 (red)-conjugated secondary anti-
bodies (Molecular Probes) were applied at 1:600 dilutions
for 1 h at room temperature.
RNA extraction, reverse transcription, and real-time PCR
Total RNA was extracted from E12.5 wild-type and
Shh / lungs using the RNeasy Mini kit (Qiagen). cDNA
was synthesized from 1 Ag of total RNA with four units of
Omniscript reverse transcriptase (RT) (Qiagen) in 20 Al,
using 0.5 Ag random hexamer primers (Invitrogen) accord-
ing to the manufacturer’s instructions. PCR was performed
using 20 Al of a 1:10 dilution of a specific cDNA to
confirm a single product with the desired length. Real-
time PCR was performed in the iCycler Iq detection
system (Bio-Rad); each reaction contained 25 Al of the
2X Quantitect SYBR Green (Qiagen) PCR Master Mix,
3 Al forward primer-f (5 AM), 3 ul reverse primer-r (5
AM), 5 Al of a 1:10 dilution of a specific wild-type or
Shh/ cDNA, and 14 Al H2O. PCR conditions: enzyme
activation program (95jC for 15 min), amplification and
quantification program repeated 45 times (94jC for 15 s,
58jC for 30 s, and 72jC for 30 s), and melting curve
program (55–95jC with a heating rate of 0.025jC/s).
PCR primers, spanning two exons, are listed below
followed by PCR product size (bp):
GAPDH:(f)5 V-TTCACCACCATGGAGAAGGC-
3V;(r)5VGGCATGGACTGTGGTCATGA-3V;236.
Wnt2b: ( f )5 V-CACCCGGACTGATCTTGTCT3 V;
(r)5VGCCACAACACATGATTTCACA3V;142.Wnt5a:(f)5VAATCCACGCTAAGGGTTCCT-3V;(r)5V-
GAGCCAGACACTCCATGACA-3V;128.
Wnt2:(f)5V-GCAACACCCTGGACAGAGAT-3V;(r)5V-
ACAACGCCAGCTGAAGAGAT-3V;103.Results and discussion
Shh/;Gli3/ lung exhibits increased growth compared
with Shh/ lung
Gross morphological analyses of E12.5, E13.5 Shh/;
Gli3/ double mutant lungs (Fig. 1) by whole-mount
immunolabeling with an antibody against Hnf-3h, an en-
dodermal marker (Yasui et al., 1997), and E15.5 Shh/;
Gli3/ lung sections by hematoxylin and eosin (HE)
staining (Fig. 1) reveal that the Shh/;Gli3/ lungs show
increased growth compared with age-matched Shh/
lungs, but patterning defects persist (Figs. 1 and 5A). There
appears to be more epithelial buds with smaller lumen
and a denser mesenchyme as shown in the E15.5 HE-
stained Shh/; Gli3/ section than in E15.5 Shh/
(Figs. 1g–i). Our finding that absence of Gli3 function in
Shh/;Gli3/ lungs yields a mutant lung with enhanced
growth potential compared with the Shh/ lungs dem-
onstrates the interplay between Shh and Gli3 functions,
which is conserved in the lung as in the limb and ventral
neural tube. Albeit, the partial rescue in growth with
persistent patterning defects in Shh/;Gli3/ lung
(Fig. 1 and Fig. 5A) suggests that there is a strict
requirement for Shh (Litingtung et al., 1998; Pepicelli et
al., 1998) and Gli3 (Grindley et al., 1997; Motoyama et
al., 1998) functions during lung development. Based on
previous observations in the neural tube (Litingtung and
Chiang, 2000) and limb (Litingtung et al., 2002; te
Welscher et al., 2002), it is postulated that the repressor
form of Gli3 (Gli3R), which is generated at a higher level
in the absence of Shh signaling, may contribute to growth
suppression. Hence, one interpretation is that removing
Gli3R, essentially by deleting Gli3, could enhance the
growth potential of the Shh/ lung, as has been observed
in other organ systems, emphasizing the conserved role of
Gli3R in growth regulation. Shh signaling, based on Gli1
and Ptch1 expressions, is not restored in the Shh/;
Gli3/ double mutant lung (Figs. 5A-c,f). This initial
finding suggests that while lack of Shh signaling leads to
severe lung hypoplasia, genetically deleting Gli3 from the
Shh/ lung, hence abrogating Gli3R function, appears to
have a positive effect on the overall growth of the
resulting Shh/;Gli3/ double mutant lung.
Gli3R level is higher in Shh/ lung in vivo and in wild-type
cyclopamine-treated lung in culture
By Western analysis of freshly dissected E12.5 wild-type
and Shh/ lungs, we show that Shh/ lungs exhibit
Fig. 1. Morphology of Shh/;Gli3/ lung compared with Shh/ and wild-type (WT). Hnf3h immunostaining of WT, Shh/, and Shh/;Gli3/ E12.5
(a–c) and E13.5 (d– f) lungs, showing less severe hypoplasia of the Shh/;Gli3/ (c,f) compared with Shh/ (b,e) lungs. Hematoxylin and eosin staining of
E15.5 WT, Shh/, and Shh/;Gli3/ lung tissue sections (g– i). There appears to be more epithelial (epi) buds (c,f,i) with smaller lumen (i) and a more
compact mesenchyme (mes) (i) in Shh/;Gli3/ compared with Shh/ lungs (b,e,h). Magnification 400 for panels a– f and 200 for panels g– i.
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concomitant decrease in the level of full-length Gli3 (Gli3-
190) (Fig. 2A, lanes 1 and 2). The observation that a low
level of Gli3R is normally present in wild-type lungs (Fig.
2A, lane 2) suggests that the relative balance of Gli3R and
full-length Gli3 may be important for normal lung devel-
opment. This result is consistent with in vivo findings in the
limb whereby a gradient of Gli3 processing exists across the
limb bud, with the highest level of Gli3R in the anterior
domain, farthest from the source of Shh which emanates
from the posterior margin (Litingtung et al., 2002; Wang et
al., 2000). Cyclopamine, a plant-derived steroidal alkaloid,
has been shown in several studies to downregulate Shh
signaling (Chiang et al., 1999; Cooper et al., 1998; Incar-
dona et al., 1998), by direct binding to Smoothened (Smo)
(Chen et al., 2002), a receptor that mediates hedgehog
signaling. Here, we show that cyclopamine treatment of
E11.5 wild-type mouse lungs results in dissociation of
mesenchymal cells from the epithelium (Fig. 2B-b, arrows
and inset) and elevated levels of Gli3R (Fig. 2C, comparelanes 1 and 2), consistent with the in vivo finding that
Shh/ lung contains higher levels of Gli3R (Fig. 2A, lane
1), suggesting that blockade in Shh signaling promotes Gli3
processing in the developing lung. As a control for the
different species of Gli3 observed, we loaded protein lysates
from Gli3/ embryos which, as expected, did not show
Gli3-specific protein bands (Fig. 2A, lane 3).
Shh/;Gli3/ mesenchyme shows increased proliferation
in vivo
To further investigate the increase in growth potential
of the Shh/;Gli3/ lung compared with Shh/ lung
(Fig. 1), we determined the proliferative capacity of wild-
type and mutant lungs by in vivo labeling with bromodeox-
yuridine (BrdU), a nucleotide analog that incorporates into
replicating DNA. BrdU pulse-labeling revealed a relatively
higher percentage of proliferating mesenchymal cells in the
Shh/;Gli3/ lung (43.9%) compared with the Shh/
mutant (35.8%) (Fig. 3), suggesting that the increase in
Fig. 2. Shh signaling regulates Gli3 processing in the mouse lung. (A) Protein extracts from freshly dissected E12.5 WT lung (lane 2), Shh/ lung (lane 1), and
Gli3/ embryo (lane 3) were immunoblotted and probed with Gli3-specific antibody recognizing a prominent 190K band and several 83K to 86K bands,
corresponding to full-length (Gli3-190) and processed repressor forms (Gli3R) of Gli3, respectively. Note Shh/ lung (lane 1) contains a higher level of Gli3R,
with a corresponding reduction in Gli3-190, relative toWT (lane 2). The Gli3 antibody recognizes several nonspecific proteins (asterisks).Gli3/ embryo extract
was used as a control for the absence of Gli3-specific bands. (B) E11.5 WT lungs were treated with cyclopamine, an Shh signaling antagonist, at a final
concentration of 4 Ag/ml in serum-free lungmedium for 48 h. The cyclopamine-treated lung (b) shows less epithelial branching and loosening of the mesenchymal
tissue (arrows and inset) compared with control lung with no cyclopamine (a). Magnification 500 for a,b. (C) Protein extracts from E11.5 WT lungs, untreated
(lane 1) or treated (lane 2) with cyclopamine, as described above, and cultured for 30 h were immunoblotted and probed with Gli3-specific antibody.
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1) contributes, at least in part, to its lower proliferative
capacity. The Shh/;Gli3/ lung epithelium also dis-
played a higher proliferative capacity (51.3%) compared
with the Shh/ epithelium (47.7%) (Fig. 3). Gli3R has
been shown to preferentially accumulate in the nucleus of
expressing cells (Dai et al., 1999; Wang et al., 2000); hence,
it is anticipated that Gli3R could exert its effects by
affecting the transcription of target genes related to growth
and differentiation.
Cyclin D1 level appears downregulated in Shh/ and
derepressed in Shh/;Gli3/ lungs, while cyclins D2, D3,
and myc levels remain unaltered
The Shh signaling pathway has been implicated in the
regulation of proproliferative genes such as myc and cyclins,
but whether their expressions are affected in the Shh/ lung
and whether Gli3R plays a role have not been documented.
Cyclins and cyclin-dependent kinases (CDKs) are evolu-
tionarily conserved proteins that are essential for cell cycle
control in eukaryotes. Cyclin–CDK holoenzyme com-
plexes, such as cyclin D–CDK4/6 and cyclin E/CDK2,regulate G1/S cell cycle transitions. The activities of CDKs
are also negatively regulated by specific CDK inhibitors
(Ekholm and Reed, 2000; Miller and Cross, 2001; Nurse,
1994; Sherr, 1993; Sherr and Roberts, 1999). Numerous
reports implicate Shh signaling in cell cycle regulation: the
mitogenic effect of Shh during hair follicle development
was found to be mediated by Gli2 activator which functions
to upregulate cyclins D1 and D2 (Mill et al., 2003); Shh
opposes epithelial cell cycle arrest and promotes epidermal
hyperplasia (Fan and Khavari, 1999); N-myc and cyclins D1
and D2 were found to be upregulated by Shh signaling in
the proliferation of cerebellar granule neuron precursors in
culture (Ciemerych et al., 2002; Kenney and Rowitch, 2000;
Kenney et al., 2003); cyclopamine has been shown to block
proliferation and downregulate myc and cyclins D1, D2, and
E1 expressions in a murine medulloblastoma cell line,
implicating Shh signaling in regulating the expression of
these genes, either directly or indirectly (Berman et al.,
2002); cyclin D2 was identified as a target gene in Gli1-
induced cellular transformation (Yoon et al., 2002); and
overexpressing Shh in the developing lung leads to en-
hanced epithelial and mesenchymal cell proliferation (Bel-
lusci et al., 1997a). The function of another mammalian
Fig. 3. Shh/; Gli3/ lung displays more cells at S phase compared with
Shh/ by in vivo BrdU pulse-labeling. Histogram showing the
percentage of BrdU-labeled cells in the epithelium and mesenchyme of
E13.5 Shh/;Gli3/ lungs compared with Shh/ and WT control.
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linked to chondrocyte proliferation during endochondral
skeleton development and cyclin D1 upregulation (Long
et al., 2001). Moreover, Drosophila hedgehog (Hh) has been
implicated in the control of cell growth and proliferation
during eye development, by promoting the transcription of
cyclins D and E (Duman-Scheel et al., 2002).
The E-type cyclins partner with CDK2 and function
during progression of mammalian cells through the G1/S
phase. They show high expression patterns in many tissues
such as the brain and lung during periods of active prolifer-
ation in the developing mouse embryo (Geng et al., 2001).
Cyclin E level does not appear to be altered in Shh/ lung
compared with wild-type (Fig. 4B); however, since the
Western analysis readout represents overall expression of
cyclin E in whole lungs, we cannot rule out the possibility
that cyclin E may be expressed at lower levels in the wild-
type lung mesenchyme compared with the epithelium; there-
fore, a decrease in its expression in Shh/ lung mesen-
chyme could be masked by a higher unaltered level of cyclin
E expression in the Shh/ lung epithelium. To resolve this
issue, we tested cyclin E antibodies from several sources by
immunohistochemistry on cryosections and antigen-re-
trieved paraffin sections, but failed to obtain positive stain-
ing, indicating these cyclin E antibodies were not suitable for
tissue sections. In contrast, we found an overall reduction in
the expression level of cyclin D1, required for G1 progres-
sion (Quelle et al., 1993), in the E12.5 Shh/ lung com-
pared with wild-type by Western blot (Fig. 4B). By
immunohistochemistry, the decrease in cyclin D1 expression
was found in both the E13.5 Shh/ lung epithelium and
mesenchyme (Fig. 4A-b), compared with wild-type which
expresses cyclin D1 in both epithelium (arrow) and mesen-chyme (arrowheads) (Fig. 4A-a). The expression of cyclin
D1 is strikingly higher in the lung epithelium than the
mesenchyme (Fig. 4A-a), consistent with the notion that
proliferation is important for expansion of the lung epithe-
lium during branching morphogenesis, although bud out-
growth per se does not appear to require localized cell
proliferation (Nogawa et al., 1998). The bronchial smooth
muscle (Fig. 4A-a, red arrowhead) also shows detectable
cyclin D1 staining. The expression level and distribution of
cyclin D1 appear to be elevated in both the epithelium and
mesenchyme of Shh/;Gli3/ lung (Fig. 4A-c), compared
with Shh/ (Fig. 4A-b). These findings are consistent with
the proliferative defects observed in Shh/ lung and partial
recovery of epithelial and mesenchymal proliferation in
Shh/;Gli3/ (Fig. 3), implicating Shh signaling, directly
or indirectly, in the regulation of cyclin D1 in the lung, as
confirmed by Western analysis (Fig. 4B). Since cyclin D1
has also been identified as a key transcriptional target of
Wnt–h-catenin signaling (Behrens, 2000; Morin, 1999;
Shtutman et al., 1999; Tetsu and McCormick, 1999), which
is operative during lung development (Mucenski et al., 2003;
Shu et al., 2002; Tebar et al., 2001), it is difficult to discern if
alteration in cyclin D1 expression observed in Shh/ lung
(Fig. 4A-b and Fig. 4B) is a direct consequence of lack of
Shh signaling or indirectly due to aberrant Wnt signaling.
Other pathways have also been linked to cyclin D1 tran-
scriptional activation (Hu et al., 2001; Zhao et al., 2001).
Moreover, it is likely that the epithelial expression of cyclin
D1 (Figs. 4A-a–c) is not regulated directly by Shh signaling,
since its targets, Ptch1 and Gli1, are not normally expressed
in the lung epithelium. Hence, it is plausible to suggest that
lung epithelial cyclin D1 expression is under the control of a
mesenchymally derived signal which appears to be affected
in the Shh/ but upregulated in the Shh/;Gli3/ lung.
The Drosophila counterpart of vertebrate Gli proteins, cubi-
tus interruptus (Ci), which mediates Hh signaling, was
shown to bind to the cyclin E promoter in mediating
transcriptional activation of the gene. Overexpression of Ci
induces G1-arrested cells to progress through S phase
(Duman-Scheel et al., 2002). Whether Shh signaling directly
regulates the expression of Cyclin D1 via Gli activation in
the mesenchyme remains to be determined.
We also examined the expressions of other D-type
cyclins, namely cyclins D2 and D3 (Figs. 4A-d–f,g–i).
Cyclin D2 shows high expression in the E13.5 wild-type
lung (Fig. 4A-d), predominantly in the proximal epithelium
(arrow) with lower levels distally (arrowhead). Cyclin D2 is
also expressed throughout the lung mesenchyme (Fig. 4A-d)
but was not observed in the more proximal regions around
the bronchial smooth muscles, unlike D1. The expression
levels of cyclin D2 in E13.5 Shh/ and Shh/;Gli3/
lungs seem comparable to wild-type, and the proximal-distal
differential distribution of cyclin D2 in the epithelium is also
maintained (Figs. 4A-d–f). This finding suggests that Shh
signaling in the developing lung does not affect cyclin D2
expression, unlike cyclin D1. Myc has been shown to
Fig. 4. Expressions of cyclin E and D-type cyclins in the WT and mutant lungs. (A) Immunohistochemical labeling of E13.5 WT, Shh/, and Shh/;Gli3/
lungs with cyclin D1 (a–c), D2 (d– f), or D3 (g– i) antibodies. Cyclin D1 is expressed in both the epithelial (arrow) and mesenchymal (arrowheads)
compartments of the developing lung. The bronchial smooth muscle is indicated by a red arrowhead. Expression of cyclin D1 in the epithelium (epi) is higher
than in the mesenchyme (mes). Expression of cyclin D1 in Shh/ lung is clearly downregulated in both epi and mes compartments and appears to be enhanced
in the Shh/;Gli3/ lung (c), compared with Shh/ (b). Cyclins D2 and D3 show higher expressions in the proximal epithelium, lower levels distally and
throughout the mesenchyme in all three genotypes. High mesothelium expression of cyclin D3 is also evident (arrowheads in g– i). (B) Western blot analysis of
E12.5 WT and Shh/ lungs, probed with antibodies against cyclins D1 and E, showing downregulation of cyclin D1 but no significant alteration in cyclin E
expressions in the Shh/ compared to WT; a-tubulin was used as a control for loading. Magnification 100 for panel A.
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Roger et al., 1999); likewise, loss of N-myc function in mice
has been shown to disrupt cyclin D2 expression in the
cerebellar primordium (Knoepfler et al., 2002). In the mouse
fetal lung, N-myc expression (Serra and Moses, 1995; Serra
et al., 1994) is restricted to the bronchial epithelium, while c-
myc is expressed exclusively in the mesenchyme (Hirning etal., 1991). Both N-myc and c-myc expressions coincide with
regions undergoing proliferation (Hirning et al., 1991;
Schmid et al., 1989). We did not observe significant alter-
ation in the levels of N-myc or c-myc transcripts in E12.5
Shh/ lung compared with wild-type by in situ hybridiza-
tion (Figs. 5A-m–p), suggesting that the myc genes do not
appear to play a significant role in the Shh/ lung pheno-
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expression of cyclin D2 is not altered in the Shh/ lung
(Fig. 4A-e).
Cyclin D3 shows distinct expression at the periphery of
the lung (Figs. 4A-g–i, arrowheads), along the visceral
pleura which consists squamous epithelium also known as
the mesothelium (Colvin et al., 2001; Weaver et al., 2003).
Cyclin D3 is also expressed in the epithelium, more proxi-
mally like cyclin D2, and uniformly throughout the mesen-
chyme of the E13.5 lung (Fig. 4A-g). Its expression was also
detected in the bronchial smooth muscle region lining the
bronchial epithelium (Fig. 4A-g, arrow). The expression and
distribution of cyclin D3 in Shh/ and Shh/;Gli3/
lungs were comparable to the wild-type (Figs. 4A-g–i),
except for a lack of bronchial smooth muscle cells (see
Fig. 6). While all three D-type cyclins show overlapping
expression domains, they also display unique expression
patterns in the developing lung at E13.5, suggesting that
some of their functions may be distinct. Findings from
previous studies suggest that the D-cyclins are largely
exchangeable in most tissues, and complete functional abla-
tion of two of the three D-cyclins results in ubiquitous
upregulation of the remaining intact cyclin during embryo-
genesis, apparently via a compensatory feedback loop; the
precise mechanism of which has not been unraveled. Hence,
cyclin D2-only mice displayed essentially normal develop-
ment in most tissues (Ciemerych et al., 2002). However,
lower levels of one cyclin such as cyclin D1 in the Shh/
lung (Fig. 4A-b) may not necessarily trigger the ‘‘compen-
satory feedback.’’ By immunohistochemistry, we did not
observe compensatory upregulation of cyclins D2 or D3 in
the Shh/ lung (Figs. 4A-e,h). However, we cannot rule out
the possibility that there could be minor changes in cyclins
D2 and D3 expressions that cannot be detected by immuno-
labeling. Hence, the downregulation of cyclin D1 in Shh/
lung, and its relative increase in Shh/;Gli3/ could
contribute, at least in part, to the proliferative defect and
partial rescue in these mutant lungs, respectively. Certainly,
the role of other cell cycle regulatory factors, such as CDKs,
CDK inhibitors, and tumor suppressors in the Shh/ lung
phenotype, awaits further investigation.
Wnt expressions are not significantly altered in Shh/ lung,
except Wnt2, which is partially restored in Shh/;Gli3/
Members of the Wnt gene family encode secreted glyco-
proteins that are involved in cell–cell interactions in tissue
patterning and morphogenesis (Moon et al., 2002; van Es et
al., 2003) by activating different intracellular signaling
cascades such as the Wnt–h-catenin pathway upon interac-
tion with the Frizzled family of receptors (Hsieh et al.,
1999b; Kalderon, 2002; Miller and Moon, 1996; Moon et
al., 1997; Yang-Snyder et al., 1996). Activation of the Wnt
pathway results in stabilization of h-catenin and its translo-
cation into the nucleus, where it complexes with HMG box
transcription factors TCF/LEF (Galceran et al., 1999), toinduce transcription of target genes in promoting cell cycle
progression (Behrens et al., 1996; Eberhart and Argani,
2001; Morin et al., 1997; Yokota et al., 2002). Several Wnts
are expressed in the developing lung including mesenchymal
Wnt2 (Bellusci et al., 1996; Levay-Young and Navre, 1992),
Wnt2b (Wnt13) (Lin et al., 2001; Zakin et al., 1998), Wnt5a
(Li et al., 2002), and epithelial Wnt7b (Shu et al., 2002).
There are indications that modulating the hedgehog pathway
can potentially affect the Wnt pathway and vice versa:Wnt2b
and Wnt5a were candidate genes found to be upregulated in
basal cell carcinomas with abnormal hedgehog signaling
(Bonifas et al., 2001; Mullor et al., 2001); glycogen synthase
kinase 3 (GSK3), a negative regulator of Wnt signaling
(Kalderon, 2002; Morin, 1999; Wharton, 2003), has been
shown to antagonize Hh signaling in Drosophila by regulat-
ing the proteolysis of Ci (Aza-Blanc and Kornberg, 1999),
the invertebrate counterpart of Gli and effector of Hh
signaling (Jia et al., 2002; Price and Kalderon, 2002).
Wnt2 expression was found to be dramatically down-
regulated in Shh/ lung (Pepicelli et al., 1998); however,
whether Shh induces Wnt2 expression remains unclear,
since overexpression of Shh in the lung apparently did
not result in Wnt2 upregulation (Bellusci et al., 1997a). We
show that some Wnt2 expression is restored in the Shh/;
Gli3/ (Figs. 5A-g–i), suggesting that Gli3R contributes,
in part, to Wnt2 repression in Shh/. We found that
expressions of Wnt2b and Wnt5a were not significantly
altered in the Shh/ lung by RT-PCR (data not shown),
and Wnt7b expression in the lung epithelium, which has
been shown to regulate lung mesenchymal proliferation
(Shu et al., 2002), is not altered in Shh/ (Pepicelli et al.,
1998). Two potential Wnt targets, cyclin D1 and c-myc,
were examined in this study; while cyclin D1 is down-
regulated (Fig. 4A-b), c-myc appears unaltered in Shh/
lung (Fig. 5A-n). Therefore, whether defective Wnt sig-
naling contributes to the hypoplastic Shh/ lung pheno-
type remains unclear. Although we found that transcripts
for several Wnt ligands are not remarkably altered in
Shh/ lung, we ought to circumspect, given the possibil-
ity that the expressions or activities of Wnt mediators and
signaling components such as the Frizzled family of
receptors (Wang et al., 1996), Wnt antagonists such as
secreted frizzled-related protein (sFRP) (Heller et al.,
2002; Hsieh et al., 1999a; Tebar et al., 2001), or other
Wnt signaling effectors such as LEF1 and TCF transcrip-
tion factors (Kengaku et al., 1998; Kubo et al., 2003;
Schmidt et al., 2000; Tebar et al., 2001) may be altered in
the Shh/ lung and therefore remain to be examined.
Gli3R contributes to the repression of Foxf1 in the Shh/
lung mesenchyme
The murine Foxf1 gene (also known as Freac1 or Hfh8)
(Clevidence et al., 1994; Hellqvist et al., 1996; Pierrou et al.,
1994) encodes a forkhead or winged helix DNA-binding
domain transcription factor. During organogenesis, Foxf1 is
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Fig. 5. Expressions of developmentally regulated genes in WT, Shh/, and Shh/;Gli3/ lungs. (A) Whole-mount in situ hybridizations of wild-type (WT),
Shh/, and Shh/;Gli3/ E12.5 lungs probed with Ptch1 (a–c),Gli1 (d– f),Wnt2 (g– i), Foxf1 (j – l), c-myc (m,n), and N-myc (o,p). As shown in e and f,Gli1,
Gli1, a Shh target, remains absent in Shh/;Gli3/, as in Shh/ lungs. Ptch1 expression appears to be detectable, albeit at very low levels, in the mutant
lungs (b and c), compared to WT (a). The expressions of mesenchymal genes Wnt2 (g– i) and Foxf1 (j – l) appear to be relatively higher in the Shh/;Gli3/
compared to Shh/ lungs, although not as high as the expression in WT (g,j). c-myc and N-myc transcript levels are not significantly altered in the mutant
lungs (n,p). (B) Section in situ hybridizations on E15.5 WT, Shh/ and Shh/;Gli3/ lungs with Foxf1 (a–c), Tbx2 (d– f), Tbx3 (g– i), Tbx4 (j – l), and Tbx5
(m–o). The levels of Foxf1, Tbx2, and Tbx3 transcripts are significantly reduced in Shh/ but relatively higher in Shh/;Gli3/ lungs. Tbx4 and Tbx5
transcripts appear only slightly lower in Shh/ lungs. Magnification 320 for panel A, 100 for panel B.
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Fig. 6. Vasculogenesis appears to be enhanced but bronchial myogenesis remains absent in Shh/;Gli3/ compared with Shh/ lung. Cryosections of wild-
type (WT), Shh/, and Shh/;Gli3/ E15.5 lungs were labeled with antibodies against PECAM-1 (a– f) and Flk-1(g– i), both endothelial markers, followed
by Alexa 488-conjugated secondary antibodies. PECAM-1-positive cells, in the interstitial mesenchyme, appear to be sparse in the Shh/ but enhanced in
Shh/;Gli3/ lung (compare b and c). However, the uniform distribution of PECAM-1-positive endothelia from major pulmonary blood vessels is evident in
all three genotypes and is not significantly different in the WT and mutant lungs (d– f). Flk-1 immunolabeling also reveals enhanced Flk-1-expressing cells in
the interstitial mesenchyme of the Shh/;Gli3/ (i) compared with Shh/ lungs (h). (B) Cryosections of wild-type (WT), Shh/, and Shh/;Gli3/ E15.5
lungs were labeled with antibodies against smooth muscle actin (SMA) (a–c) and smooth muscle myosin (SMM) (d– f), followed by Alexa 488 (a–c) or Alexa
568 (d– f) conjugated secondary antibodies. While vascular smooth muscle is present in the mutants (arrows) and WT lungs (d–f), bronchial smooth muscle as
highlighted by SMA (a–c) and SMM (d– f) is evident in the WT (arrowheads) but absent in the Shh/;Gli3/ lung (arrowheads), as in Shh/ (arrowheads).
Magnification for panel A: a–c and g– i (100), d– f (200); panel B: 100.
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endoderm, suggesting its potential involvement in epitheli-
al–mesenchymal interactions (Aitola et al., 2000; Costa et
al., 2001; Mahlapuu et al., 1998; Peterson et al., 1997).
Indeed, Foxf1 is downregulated in Shh/ lung mesenchyme
(Fig. 5A-k, E12.5 and Fig. 5B-b, E15.5), although its
expression in the Shh/ lung has been previously reported
absent (Mahlapuu et al., 2001a). This difference in Foxf1
expression could be attributed to variations in the length of
exposure to the color detection medium after in situ hybrid-
ization. Nevertheless, our conclusion that Shh signaling is
required for the activation of Foxf1, based on its repression in
Shh/ lung, agrees with the previous report that Foxf1 is a
target of Shh signaling (Mahlapuu et al., 2001a).
The present study on Shh/;Gli3/ lung reveals an
interesting finding; Foxf1 is derepressed in Shh/ lung in
the absence of Gli3, although not to the levels expressed in
age-matched wild-type lung (Fig. 5A-l, E12.5 and Fig. 5B-
c, E15.5). This finding suggests that Foxf1 transcriptional
activation is, in part, dependent on Shh signaling and Gli2/3
functions as previously proposed (Mahlapuu et al., 2001a),
but it also implicates Gli3R as a negative regulator of Foxf1
transcription, emphasizing the critical role of Shh signaling
in antagonizing Gli3R activity in the developing lung.
Intriguingly, we also observed Foxf1 expression in E15.5
bronchial epithelium of both wild-type and Shh/ lungs
(data not shown). Since Foxf1+/ haploinsufficient lungs
are hypoplastic (Kalinichenko et al., 2001b; Lim et al.,
2002; Mahlapuu et al., 2001a) and a wild-type level of
Foxf1 is required for normal lung development (Costa et al.,
2001), we suggest that upregulating Foxf1 expression in the
Shh/;Gli3/ lung may contribute, in part, to its in-
creased growth potential compared with Shh/ lung. Foxf1
has been implicated in growth control, since proliferation of
the primitive streak mesoderm is reduced in Foxf1 null
embryos (Mahlapuu et al., 2001b), and it has been sug-
gested that Foxf1 may mediate the mitogenic effect of Shh
in the developing lung (Mahlapuu et al., 2001a). However,
the precise roles and targets of Foxf1 in governing cellular
processes such as proliferation and differentiation in the
developing lung await further investigation.
Tbx2 and Tbx3 expressions are significantly repressed in
Shh/ and derepressed in Shh/;Gli3/ lungs
Based on recent literature, we next directed our efforts to
examine the expression of T-box genes (Tbx), which have
been implicated as potential Fox targets (Kalinichenko et al.,
2001b; Yamagishi et al., 2003), in the Shh mutant lungs.
The T-box family comprises an ever-growing number of
genes, now totaling 18 in mammals (Gibson-Brown, 2002).
T-box genes (Tbx) encode DNA-binding transcription fac-
tors which regulate the functions of tissues during embryo-
genesis, in particular, tissues undergoing inductive
interactions such as the lung epithelium which expresses
Tbx1 and the mesenchyme which expresses two cognategene sets: Tbx2; Tbx3 and Tbx4; Tbx5 (Cebra-Thomas et al.,
2003; Chapman et al., 1996). The Tbx factors have been
implicated in human birth defects and cancer (Gibson-
Brown, 2002; Jacobs et al., 2000; Papaioannou, 2001);
however, the transcriptional regulators and targets of Tbx
remain largely unexplored.
By cDNA expression array analysis and RNase protec-
tion assay, the Tbx family of transcription factors such as
Tbx2, 3, 4, and 5 which, like Foxf1, are expressed in the
lung mesenchyme (Chapman et al., 1996) were found to be
diminished in Foxf1+/ mutant background (Kalinichenko et
al., 2001b), implicating the potential role of Foxf1 in the
transcriptional regulation of Tbx genes. Since Foxf1 is
downregulated in Shh/ and partially derepressed in
Shh/;Gli3/ lungs, we decided to analyze the expres-
sions of Tbx2, 3 and Tbx4,5 in these mutants.
By using antisense oligonucleotide to abrogate the func-
tions of both Tbx4 and Tbx5 (Cebra-Thomas et al., 2003), it
was shown that these transcription factors are likely impor-
tant for the expression of mesenchymal Fgf10, critical in
lung epithelial branching (Bellusci et al., 1997b; Weaver et
al., 2000). Fgf10 expression appears broader in Shh/ lung
(Litingtung et al., 1998; Pepicelli et al., 1998); in agreement,
expressions of Tbx4 and Tbx5 do not appear significantly
altered in Shh/ lung (Figs. 5B-k,n). In contrast, Tbx2 and
Tbx3 expressions are significantly repressed in Shh/ and
enhanced in Shh/;Gli3/ lungs (Figs. 5B-e,h,f,i). Our
finding suggests that Shh signaling is important in the
transcriptional regulation of Tbx2 and Tbx3. While Tbx2
and Tbx3 transcriptional activation by an Shh mediator such
as Gli cannot be ruled out, previous reports have implicated
other factors in the transcriptional induction of Tbx genes
such as Bmp2 induction of Tbx2 in chick heart development
(Yamada et al., 2000), Foxa2 and Foxc2 induction of Tbx1
in murine pharyngeal endoderm and head mesenchyme
development, respectively (Yamagishi et al., 2003). Shh
signaling has been proposed to maintain the expression of
Foxa2 and Foxc2 in the regulation of Tbx1 (Yamagishi et
al., 2003). Our observation that Tbx2 and Tbx3 expressions
are significantly repressed in Shh/ (Figs. 5B-e,h) and
derepressed in Shh/;Gli3/ lungs (Figs. 5B-f,i) bears
good correlation with the Foxf1 expression levels in these
mutants (Figs. 5B-b,c). Therefore, we suggest that Shh
signaling regulate Tbx2 and Tbx3 expressions via Foxf1 in
the developing lung. Consistent with this notion, Tbx2 and
Tbx3 expressions are downregulated in Foxf1+/ lung (Kali-
nichenko et al., 2001b). Microarray analysis of Tbx2-
induced gene expression revealed numerous, potentially
interesting, transcriptional targets including genes involved
in cell cycle control and cell adhesion (Chen et al., 2001).
Both Tbx2 and Tbx3 have been linked to inhibition of
senescence in primary mouse embryonic fibroblasts (Brum-
melkamp et al., 2002; Jacobs et al., 2000). We suggest that
Tbx2 and Tbx3 could also play a role in lung growth and
proliferation; their downregulation could contribute, in part,
to the Shh/ hypoplastic lung phenotype. The specific role
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elucidated with the future identification of specific Tbx2-
and Tbx3-regulated genes.
Vasculogenesis is significantly impaired in Shh/ and
partially restored in Shh/;Gli3/ lung
During mouse embryogenesis, the lung mesenchyme
undergoes a series of differentiation events with develop-
ment of the pulmonary capillary network beginning around
E10. It is believed that the capillary network is established
when a subpopulation of lung mesenchymal cells undergoes
a process known as vasculogenesis which involves the
migration and coalescence of these mesenchymal cells into
blood islands or hemangioblast clusters, which are precur-
sors of endothelial and hematopoietic cells (Akeson et al.,
2000; deMello et al., 1997; Gebb and Shannon, 2000;
Schachtner et al., 2000). This capillary network, formed
by lumenal connections and assembly of endothelial cells, is
thought to eventually make connections with the major
pulmonary blood vessels to establish the lung circulatory
system (deMello and Reid, 2000; Hislop, 2002). We exam-
ined the expression of markers associated with endothelial
cell function such as platelet endothelial cell adhesion
molecule-1 (PECAM-1) and vascular endothelial growth
factor R2 (VEGF-R2), a receptor tyrosine kinase also
known as fetal liver kinase-1 (Flk-1), to investigate the role
of Shh signaling in pulmonary vasculogenesis. Flk-1 medi-
ates signaling by VEGF, an endothelial-specific mitogen
secreted by the lung epithelium (Gebb and Shannon, 2000;
Healy et al., 2000) and has been shown to be critical for
vasculogenesis and hematopoiesis (Shalaby et al., 1995,
1997).
Interestingly, we found that the level of endothelial cell
differentiation in the E15.5 Shh/ lung mesenchyme is
reduced, based on PECAM-1 and Flk-1 staining, while
Shh/;Gli3/ lung mesenchyme displays a relatively
increased distribution of PECAM-1- and Flk-1-positive cells
(Figs. 6A-b–c,h–i). PECAM-1 and Flk-1 stainings show
less continuity in Shh/ (Figs. 6A-b,h), suggesting possible
defects in migration and/or coalescence of endothelial cells
to form the capillary bed (Akeson et al., 2000), while in
Shh/;Gli3/ lung, the severity of this problem appears
alleviated based on the staining pattern of both endothelial
markers (Figs. 6A-c,i). Indeed, Flk-1 function has been
linked to the movement of blood cell precursors (Shalaby
et al., 1997). The present finding suggests that Shh signaling
plays a critical role in the formation of the pulmonary
capillary network. Moreover, the higher level of Gli3R in
Shh/ lung (Fig. 2A, lane 1) appears to negatively regulate
vasculogenesis which is less affected in Shh/;Gli3/
lung.
Foxf1 plays a critical role in pulmonary vasculogenesis,
because haploinsufficient Foxf1+/ embryos and newborn
mice, expressing relatively low levels of Foxf1 in the lung
(20% of wild-type levels), die of severe alveolar hemor-rhage due to defects in vasculogenesis and alveologenesis
(Kalinichenko et al., 2001b). These Foxf1+/ mice have
diminished expression of PECAM-1 and Flk-1, whereas
Foxf1+/ mice expressing near normal levels of Foxf1
displayed normal levels of PECAM-1 and Flk-1 (Kalini-
chenko et al., 2001b). In the adult mouse lung, Foxf1-
expressing cells colocalized with PECAM-1-positive alve-
olar endothelial and peribronchiolar smooth muscle cells
(Costa et al., 2001). PECAM-1 stainings in the endothelium
of large pulmonary blood vessels, which do not normally
express Foxf1 (Kalinichenko et al., 2001a), were compara-
ble in all three genotypes (Figs. 6A-d–f). Among Foxf1+/
surviving adult mice, butylated hydroxytoluene (BHT)
treatment causes fatal lung injury due to severe hemor-
rhage; BHT caused a 10-fold reduction in Foxf1 level
accompanied by increased alveolar endothelial cell apopto-
sis (Kalinichenko et al., 2002b). Hence, it is plausible to
suggest that the defect in PECAM-1 and Flk-1 expressions
observed in the Shh/ may be linked to repressed Foxf1
expression, while Shh/;Gli3/ lung, which expresses a
relatively higher level of Foxf1, shows a concomitant
recovery of endothelial marker expressions (Figs. 6A-c,i).
However, it is possible that other factors are involved such
as vascular endothelial growth factor (VEGF) (Galambos et
al., 2002; Gebb and Shannon, 2000; Healy et al., 2000; Ng
et al., 2001; Zeng et al., 1998) and TGF-h1 (Zeng et al.,
2001).
Foxf1+/ mice reported by another group also exhibited
lung and foregut malformations resulting in 90% perinatal
mortality but with apparently no significant defects in lung
vascularization (Mahlapuu et al., 2001a). It is possible that
the expression level of Foxf1 in these mutant mice was not
low enough to cause vasculogenesis problems but sufficient-
ly downregulated to cause lung hypoplasia. It is apparent that
there is variability in the levels of Foxf1 expressed from
different Foxf1+/ embryos (Kalinichenko et al., 2001b).
This observation suggests that less than wild-type level of
Foxf1 is sufficient to promote near normal vasculogenesis
during early embryogenesis (Mahlapuu et al., 2001a), at least
based on endothelial marker expression and distribution. In
agreement, we observed enhanced vasculogenesis in Shh/;
Gli3/ lung (Figs. 6A-c,i), although its Foxf1 transcript
level is relatively less than wild-type (Figs. 5A-j,l and Figs.
5B-a,c). Foxf1, expressed in the mesenchyme, has been
implicated in basement membrane extracellular matrix de-
position and tight junction formation between cells of two
interacting layers such as the mesenchymally derived endo-
thelial cell with type I epithelial cell or the bronchial smooth
muscle cell with the bronchiolar epithelium of the lung.
Decreased Foxf1 expression has also been linked to gall
bladder defects and reduced expression of adhesion mole-
cules, vascular cell adhesion molecule-1 (VCAM-1), and a5
integrin (Kalinichenko et al., 2002a). Foxf1+/ mice show
tight junction disruptions which could result in impaired
epithelial–mesenchymal interaction (Costa et al., 2001;
Kalinichenko et al., 2001a,b), hence providing one plausible
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muscle or endothelial cell homeostasis.
Bronchial myogenesis remains defective in Shh/;Gli3/
lung
The mesenchymal cells of the developing lung can give
rise to visceral smooth muscle cells which express smooth
muscle alpha-actin (SMA) and smooth muscle myosin
(SMM) (Relan et al., 1999; Yang et al., 1998, 1999). Since
vasculogenesis defect is less severe in the Shh/;Gli3/
compared with Shh/ lung, we thought it would be
interesting to examine whether differentiation along another
cell lineage, namely, bronchial smooth muscle (BSM) which
is absent in the Shh/ lung (Pepicelli et al., 1998) would be
restored in Shh/;Gli3/ lung. Moreover, Foxf1 expres-
sion is relatively higher in Shh/;Gli3/ compared with
Shh/, so we wondered whether this increase would be
accompanied by a concomitant recovery of BSM in Shh/;
Gli3/ lung, since Foxf1 is expressed in the peribronchio-
lar smooth muscle layer (Costa et al., 2001; Kalinichenko et
al., 2001a) and has been implicated in Shh-induced myo-
genesis in lung mesenchyme explants (Weaver et al., 2003).
In Foxf1+/ newborn lung, a disruption of the cell interface
between the BSM and epithelial layers was reported along
with an increase in apoptosis of BSM cells (Kalinichenko et
al., 2001b). Our results, by immunohistochemistry using
both SMA and SMM antibodies on E15.5 lungs, indicate
that, while vascular smooth muscles lining the major pul-
monary blood vessels (Hall et al., 2000, 2002; Hislop, 2002)
are present in both Shh/ and Shh/;Gli3/ lungs (Fig.
6B, arrows in b,c,e,f ), bronchial smooth muscle remains
absent (Fig. 6B, arrowheads in b,c,e,f). The wild-type lung
shows clear presence of bronchial smooth muscle as high-
lighted by the smooth muscle markers (Fig. 6B, arrowheads
in a,d). This finding suggests that while differentiation along
the alveolar capillary endothelial cell lineage is enhanced in
Shh/;Gli3/ lungs, differentiation along the bronchial
smooth muscle lineage remains defective. This observation
implies that Gli3R does not contribute significantly to the
lack of BSM in Shh/ lung. In conclusion, our result
suggests, while upregulating Foxf1 implicated in pulmonary
vasculogenesis in Shh/;Gli3/ lung partially restored the
distribution of PECAM-positive endothelial cell types, in
contrast, that level of Foxf1 is not sufficient to restore BSM.
Hence, the role of Foxf1 in bronchial myogenesis still awaits
further investigation.Acknowledgments
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